/ 1 Rue Gaston Veil
Sector#Biotechnology - Therapeutics
AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance and preserves useful immune responses in inflammatory, autoimmune and degenerative diseases.
Anti-CD45RC monoclonal antibody to deplete effector T cells and preserve regulatory and memory T cells.
IL-34 cytokine to induce tolerogenic macrophages/DCs and regulatory T cells.
Founded by a team with a long cutting-edge translational expertise in regulatory T cells and mechanisms of tolerance.
Upcoming eventsAll events
KNOWLEDGE FOR GROWTH 2023Event by: flanders.bio
BIO International Convention 2023Event by: Biotechnology Innovation Organisation
Innovation for Health 2023Event by: Hyphen Projects
Program Manager AgrifoodTech
Postdoctoral Research Scientist – Neuroimmune Organoids in Neurodegeneration